Elutia: Funding, Investors & Team (Sep 2026)
Elutia is a regenerative medicine company that is currently operating in the commercial stage. They are dedicated to developing innovative products to enhance the outcomes of surgical procedures, particularly for patients receiving implantable medical devices. Using their unique tissue processing technology, Elutia has created a range of advanced regenerative products that closely mimic natural biological materials.
Elutia has raised $23.8M across 2 funding rounds on record, the most recent an undisclosed round of $13.3M announced in Jun 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Elutia Company Profile and Key Stats
Latest funding round on record: Jun 2024.
Elutia Funding Rounds
Elutia raised $10.5M in an undisclosed round announced in Sep 2023.
9 months later, an undisclosed round of $13.3M was announced in Jun 2024.
Elutia Founders and Leadership Team
No contact details are on record for this team yet.
Elutia Funding Compared to Other Biotechnology Startups
Elutia's latest round of $13.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Elutia in Biotechnology and Silver Spring
Companies Similar to Elutia
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Elutia Funding FAQs
What does Elutia do?
Elutia is a regenerative medicine company that is currently operating in the commercial stage. They are dedicated to developing innovative products to enhance the outcomes of surgical procedures, particularly for patients receiving implantable medical devices. Using their unique tissue processing technology, Elutia has created a range of advanced regenerative products that closely mimic natural biological materials.
How much funding has Elutia raised?
Elutia has raised $23.8M across 2 rounds on record. The most recent is an undisclosed round of $13.3M announced in Jun 2024.
When did Elutia last raise funding?
Elutia's most recent funding round on record is an undisclosed round of $13.3M, announced in Jun 2024.
Who founded Elutia?
FundedIQ lists C Randal Mills (Founder) at Elutia.
Where is Elutia headquartered?
Elutia is based in Silver Spring, Maryland, United States.
How many employees does Elutia have?
Elutia is in the 101-250 employee band.
How does Elutia's funding compare to other Biotechnology startups?
Elutia's latest round of $13.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Elutia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Elutia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.